Tirzepatide is the first dual-target therapy that activates both GIP and GLP-1 receptors, helping manage blood sugar levels ...

The Medicines and Healthcare products Regulatory Agency has issued an alert regarding contraception and weight loss and ...

Dizziness, sudden hunger, or easy anger? Could be a sign of low blood sugar. Recognize these 5 symptoms before it's too late!

Drugs that promise rapid and effortless weight loss once seemed like the stuff of fairytales. Now, even if we’re not “on the ...

Mounjaro, one of the brand names for tirzepatide, is a drug that is beneficial for people with type 2 diabetes. This ...

Dr. Reddy's faces revenue slowdown post gRevlimid boost, but new investments and partnerships offer long-term growth ...

The following is a summary of “Association of Glucagon-like Peptide-1 Receptor Agonists with Optic Nerve and Retinal Adverse ...

With three months since its launch in India, according to latest Pharmatrac data, Mounjaro clocked Rs 12.6 crore in sales in May 2025—a threefold increase from March ...

Patients who use GLP1 drugs to help control their type 2 diabetes are at an upward risk of developing age-related macular ...

Treatment should be stopped if nonarteritic anterior ischemic optic neuropathy, which can cause vision loss, is diagnosed.

The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other ...

A YouTuber has given a hour-by-hour breakdown of what happens to the human body if you eat nothing for three days ...